Lufyllin

Active Ingredient(s): Dyphylline
FDA Approved: * August 16, 1976
Pharm Company: * MEDPOINTE PHARM HLC
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lufyllin Overview

Diprophylline (INN)[1] or dyphylline (USAN) (trade names Dilor, Lufyllin), is a xanthine derivative with bronchodilator and vasodilator effects. It is used in the treatment of respiratory disorders like asthma, cardiac dyspnea, and bronchitis. It acts as an adenosine receptor antagonist and phosphodiesterase inhibitor.[2][3] See also Xanthine References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw...

Read more Lufyllin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dyphylline

Recent Lufyllin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Lufyllin: (2 results)

Sorted by National Drug Code

• 0037-0521 Lufyllin 200 mg Oral Tablet by Meda Pharmaceuticals Inc.
• 0037-0731 Lufyllin 400 mg Oral Tablet by Meda Pharmaceuticals Inc.

Other drugs which contain Dyphylline or a similar ingredient: (10 results)

• DILOR Dyphylline
• DILOR-400 Dyphylline
• DYPHYLLINE 1 discussion
• DIFIL G Dyphylline + Guaifenesin2 discussions
• DILOR G Dyphylline + Guaifenesin
• DYFLEX G Dyphylline + Guaifenesin
• DYLINE GG Dyphylline + Guaifenesin
• DYPHYLLINE + GUAIFENESIN
• LUFYLLIN GG Dyphylline + Guaifenesin
• PANFIL G Dyphylline + Guaifenesin

Related Lufyllin Topics: